Retatrutide Weight Loss and Gray Market Risks

Podcast: Foodnourish Deep Dives · Pavlos Giorkas

Opublikowano: 2026-10-06

In today's episode we're diving deep into retatrutide, the groundbreaking triple hormone receptor agonist making waves in obesity treatment. We explore how scientific clinical research highlights its remarkable weight loss results for patients with obesity and diabetes, showing how it effectively regulates metabolism and blood glucose levels. We also detail its safety profile and common side effects identified in clinical trials. Furthermore, we uncover the critical real-world risks associated with gray-market sourcing, unregulated online peptides, and self-administration. Tune in to discover the clinical promise, potential side effects, and important health warnings surrounding this novel...